Skip to main content
Clinical Trials/NCT00692653
NCT00692653
Completed
N/A

Personal Patient Profile Prostate (P4) Randomized, Multisite Trial

Dana-Farber Cancer Institute6 sites in 1 country498 target enrollmentFebruary 2007
ConditionsProstate Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Dana-Farber Cancer Institute
Enrollment
498
Locations
6
Primary Endpoint
Decisional Satisfaction
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine whether or not participation in an experimental program called the "P4 program" is useful to men who are faced with choices about treatment for their early stage prostate cancer. The P4 program consists of a series of questions and information for the participant.

Before seeing the cancer specialist, participants will answer several questionnaires on a computer. This will take about 20-30 minutes. Participants may choose to do this on a computer at home or on a touch-screen computer in the clinic. Half the participants will then be shown several highly rated informational websites about prostate cancer treatments. The other half, based on the individual participant's answers, will receive the P4 program's customized written and on-screen information. Reading the information and watching videos will take about 20 minutes.

About one month later, and again 6 months, participants will complete follow-up questionnaires electronically or by mail. These questionnaires will help us understand how each participant's decision for treatment of their prostate cancer went. Answering these questionnaires should take about 20 minutes each time.

Registry
clinicaltrials.gov
Start Date
February 2007
End Date
December 2009
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Donna Berry, PhD, RN, FAAN, ACON

Director, The Phyllis F. Cantor Center

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Biopsy-proven diagnosis of prostate cancer, stage I or II
  • Diagnosis within the past 6 months
  • Has appointment with a consulting specialist at one of the clinical trial sites
  • Must be able to read and write English or Spanish at a 6th grade level
  • Must not have begun any treatment (except watchful waiting)
  • Must be able to complete baseline assessment before target clinician visit.

Exclusion Criteria

  • Advanced prostate cancer
  • Diagnosed more than 6 months ago
  • Cannot read and write English or Spanish at a 6th grade level
  • Does not have appointment at one of the clinical trial sites

Outcomes

Primary Outcomes

Decisional Satisfaction

Time Frame: Baseline to 6 months

Satisfaction with Preparation for Decision Making

Time Frame: Baseline to 1 month

Decisional Conflict

Time Frame: Baseline to 6 months

Secondary Outcomes

  • Shift in decisional control preference from pre-decision to 1 month post-treatment(Baseline to 1 month)
  • Resource utilization(Baseline to 6 months)

Study Sites (6)

Loading locations...

Similar Trials